Erenumab patient characteristics, medication adherence, and treatment patterns in the United States.

CONCLUSIONS: Almost all patients had prior use of acute or preventive therapy. Adherence to erenumab was higher than traditional oral prophylactic migraine therapies; however, overall adherence was still suboptimal. The decrease in use of acute and preventive prescription medications following initiation of erenumab suggests effectiveness in the real-world setting. PMID: 33594672 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33594672?dopt=Abstract

Source: Headache - February 16, 2021 Category: Neurology Authors: Hines DM, Shah S, Multani JK, Wade RL, Buse DC, Bensink M Tags: Headache Source Type: research